MarketPeel
Insider Trading Intelligence
Pricing
…
WC

Waage Christian

GOSS
EVP & GENERAL COUNSEL · GOSSAMER BIO, INC. · CIK 0001553179
FILING MIX · LIFETIME70%/30%
BUYS
46
SELLS
20
TOTAL VALUE
$354.6K
COMPANIES
2
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
53,960
AVG SELL PX
$7.19
TRADE KIND
SHOWING 66 / 66
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
9 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Waage Christian, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d9+55.56%+0.53%+0.68%-0.15%+0.15%—
14d9+55.56%-4.95%+1.63%-6.58%-5.62%—
30d9+77.78%-11.62%+3.00%-14.61%-17.93%—
60d9+88.89%-7.06%+3.38%-10.44%-13.31%—
90d9+100.00%-10.39%+4.43%-14.82%-18.15%—
180d9+55.56%-35.88%+6.18%-42.06%-46.18%—
1y9+88.89%-35.11%+8.42%-43.53%-53.06%—
2y9+88.89%-61.66%+16.33%-78.00%-92.26%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
GOSS · 0 shares · as of Mar 19, 2026
0203,515407,031610,546814,061202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 46 buys / 20 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
125,000——125,000Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
70,000——70,000Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
375,000——375,000Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
47,667——47,667Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
SALE
EVP, Tech Ops and Admin
440,000——0Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
SALE
EVP, Tech Ops and Admin
506,250——0Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
SALE
EVP, Tech Ops and Admin
375,000——0Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
SALE
EVP, Tech Ops and Admin
60,000——0Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
157,500——157,500Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
SALE
EVP, Tech Ops and Admin
47,667——0Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
126,667——126,667Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
506,250——506,250Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
SALE
EVP, Tech Ops and Admin
157,500——0Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
SALE
EVP, Tech Ops and Admin
126,667——0Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
440,000——440,000Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
SALE
EVP, Tech Ops and Admin
125,000——0Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
60,000——60,000Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
SALE
EVP, Tech Ops and Admin
70,000——0Mar 19, 2026Mar 20, 2026 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
53,960——53,960Jan 30, 2026Feb 3, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
506,250——506,250Jan 2, 2026Jan 5, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
84,500——814,061Jan 2, 2026Jan 5, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
125,000——710,934Oct 1, 2025Oct 2, 2025 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
440,000——440,000Mar 4, 2025Mar 6, 2025 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
35,900——35,900Jan 31, 2025Feb 4, 2025 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
17,950——84,130Jan 31, 2025Feb 4, 2025 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
35,900$1.73$62.1K35,900Jan 30, 2025Feb 3, 2025 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
17,950——84,130Jan 30, 2025Feb 3, 2025 ↗View →
GOSS
GOSSAMER BIO, INC.
SALE
EVP, Tech Ops and Admin
6,430$1.16$7.4K585,934Mar 27, 2024Mar 28, 2024 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
83,685——83,685Jan 19, 2024Jan 19, 2024 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
13,948——66,180Jan 19, 2024Jan 19, 2024 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
375,000——375,000Jan 2, 2024Jan 4, 2024 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
125,000——125,000Nov 20, 2023Nov 22, 2023 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
3,376$0.13$4223,376Jul 24, 2023Jul 26, 2023 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
13,504$1.82$24.6K45,892Jul 24, 2023Jul 26, 2023 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
47,667——47,667May 5, 2023May 9, 2023 ↗View →
GOSS
GOSSAMER BIO, INC.
SALE
EVP, Tech Ops and Admin
71,500——0May 5, 2023May 9, 2023 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
60,000——60,000May 5, 2023May 9, 2023 ↗View →
GOSS
GOSSAMER BIO, INC.
SALE
EVP, Tech Ops and Admin
90,000——0May 5, 2023May 9, 2023 ↗View →
GOSS
GOSSAMER BIO, INC.
SALE
EVP, Tech Ops and Admin
105,000——0May 5, 2023May 9, 2023 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
126,667——126,667May 5, 2023May 9, 2023 ↗View →
GOSS
GOSSAMER BIO, INC.
SALE
EVP, Tech Ops and Admin
190,000——0May 5, 2023May 9, 2023 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
70,000——70,000May 5, 2023May 9, 2023 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASE
EVP, Tech Ops and Admin
18,500$1.20$22.1K32,388Mar 20, 2023Mar 22, 2023 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
157,500——157,500Mar 20, 2023Mar 22, 2023 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
77,160——77,160Dec 16, 2022Dec 20, 2022 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
38,580——52,232Dec 16, 2022Dec 20, 2022 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
157,500——157,500Dec 7, 2022Dec 9, 2022 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASE
EVP, Tech Ops and Admin
6,934$7.21$50.0K13,888Jul 15, 2022Jul 15, 2022 ↗View →
GOSS
GOSSAMER BIO, INC.
SALE
EVP, Tech Ops and Admin
10,722$8.92$95.6K579,008Mar 23, 2022Mar 24, 2022 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
190,000——190,000Jan 6, 2022Jan 10, 2022 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
10,452——13,652Dec 22, 2021Dec 23, 2021 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
20,903——20,903Dec 22, 2021Dec 23, 2021 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
SALE
300$9.73$2.9K3,200Dec 21, 2021Dec 23, 2021 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
SALE
300$12.31$3.7K3,500Sep 21, 2021Sep 23, 2021 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
SALE
300$15.20$4.6K3,800Jun 21, 2021Jun 22, 2021 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
SALE
300$17.51$5.3K4,100Apr 15, 2021Apr 16, 2021 ↗View →
GOSS
GOSSAMER BIO, INC.
SALE
EVP & General Counsel
5,490$9.48$52.1K588,199Mar 23, 2021Mar 25, 2021 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
45,000——593,689Feb 25, 2021Mar 1, 2021 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
90,000——90,000Feb 25, 2021Mar 1, 2021 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
3,000——4,400Dec 21, 2020Dec 23, 2020 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
18,000——18,000Dec 21, 2020Dec 23, 2020 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASE
EVP & General Counsel
2,500$9.53$23.8K6,954Oct 14, 2020Oct 14, 2020 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
437——437Oct 13, 2020Oct 15, 2020 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
713——713Apr 15, 2020Apr 17, 2020 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
46,500——547,998Feb 14, 2020Feb 19, 2020 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
71,500——71,500Feb 14, 2020Feb 19, 2020 ↗View →
Other insiders · GOSS
Loading peer insiders…
About this filer
CIK 0001553179
ROLE
EVP & General Counsel
PRIMARY
GOSS
COMPANIES
2
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001553179DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback